Table 1.
Study cohort demographic information and clinical characteristics (N = 275)
| Parameter | Hepatic steatosis | No hepatic steatosis |
|---|---|---|
| N | 75 | 200 |
| Age (y) | 59.48 ± 2.89 | 58.89 ± 2.76 |
| Race n (%) | ||
| Black | 38 (50.7) | 134 (67.0) |
| White | 37 (49.3) | 66 (33.0) |
| BMI (kg/m2) | 37.2 ± 7.6 | 32.7 ± 8.1 |
| T2D, N (%) | 32 (42.7) | 47 (23.5) |
| WC (cm) | 109.6 ± 13.1 | 98.0 ± 16.4 |
| TG (mg/dL) | 153.8 ± 90.7 | 109.5 ± 51.3 |
| FG (mg/dL) | 128.1 ± 76.1 | 96.9 ± 31.1 |
| HbA1c (%) | 6.8 ± 1.8 | 6.0 ± 0.8 |
Data are means ± standard deviation, unless otherwise indicated; WC waist circumference, TG fasting serum triglyceride levels, FG fasting plasma glucose, HbA1c glycosylated hemoglobin